Vaccinex (VCNX) News Today $1.06 -0.02 (-1.85%) As of 02:30 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Vaccinex receives delisting notification from NasdaqDecember 17, 2024 | markets.businessinsider.comVaccinex Announces Receipt of Delisting Notification from NasdaqDecember 17, 2024 | markets.businessinsider.comVaccinex Shares Tumble 63% On Nasdaq DelistingDecember 17, 2024 | marketwatch.comVaccinex Faces Nasdaq Delisting Amid Financial Struggles; Shares Drop 62%December 17, 2024 | finance.yahoo.comVaccinex Faces Nasdaq Delisting: What's Going On With The Stock?December 17, 2024 | benzinga.comVaccinex, Inc.: Vaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 19, 2024 | finanznachrichten.deVaccinex Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNovember 18, 2024 | globenewswire.comVaccinex provides update on ActivMAb platformNovember 8, 2024 | markets.businessinsider.comVaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITCNovember 7, 2024 | globenewswire.comVaccinex to preset new biomarker data on HNSCCNovember 6, 2024 | markets.businessinsider.comVaccinex Reports Improved Immunity Correlating with Clinical Benefit of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer's Annual MeetingNovember 5, 2024 | globenewswire.comVaccinex reports new findings from SIGNAL-AD Phase 1b/2 trial of pepinemabNovember 1, 2024 | markets.businessinsider.comVaccinex Reports New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab at Clinical Trials on Alzheimer's Disease (CTAD) Conference in Madrid, SpainOctober 31, 2024 | globenewswire.comVaccinex announces it will present new data for Phase 1b/2 SIGNAL-AD studyOctober 26, 2024 | markets.businessinsider.comWhat's Going On With Vaccinex Stock Wednesday?September 19, 2024 | msn.comVaccinex Announces Exercise of Warrants for $6.2 Million in Gross ProceedsSeptember 18, 2024 | globenewswire.comVCNX Stock Earnings: Vaccinex Reported Results for Q2 2024August 14, 2024 | investorplace.comVaccinex Provides Update on New Findings for SIGNAL-AD Phase 1b/2 Trial of Pepinemab in Alzheimer's Disease and Plans to Pursue a Development PartnershipAugust 14, 2024 | globenewswire.comInsider Buying: Vaccinex, Inc. (NASDAQ:VCNX) Director Purchases 3,653 Shares of StockAugust 8, 2024 | insidertrades.comAlbert Friedberg Acquires 200,000 Shares of Vaccinex, Inc. (NASDAQ:VCNX) StockAugust 2, 2024 | insidertrades.comVaccinex stock tanks 40% despite positive Alzheimer’s study updateJuly 31, 2024 | msn.comVaccinex stock plunges 24% on mixed results for Alzheimer's studyJuly 31, 2024 | msn.comVaccinex, Inc. (VCNX)July 25, 2024 | finance.yahoo.comInvestors Await Key Earnings Reports as US Futures Tread Water in Friday's PremarketJuly 20, 2024 | msn.comInvestors Await Key Earnings Reports as US Futures Tread Water in Friday's PremarketJuly 20, 2024 | msn.comVaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer's DiseaseJune 6, 2024 | globenewswire.comVaccinex, Inc.: Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 16, 2024 | finanznachrichten.deVCNX Stock Earnings: Vaccinex Reported Results for Q1 2024May 16, 2024 | investorplace.comVaccinex Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | globenewswire.comVaccinex faces Nasdaq compliance challengeApril 14, 2024 | investing.comVCNX Stock Earnings: Vaccinex Reported Results for Q4 2023April 2, 2024 | investorplace.comVaccinex Reports 2023 Financial Results and Provides Corporate UpdateApril 2, 2024 | globenewswire.comVaccinex, Inc. Announces $1.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq RulesMarch 27, 2024 | globenewswire.comVaccinex CFO Scott Royer to retire, Jill Sanchez steps inMarch 6, 2024 | investing.comVaccinex Inc VCNXMarch 2, 2024 | morningstar.comVaccinex, Inc.: Vaccinex Announces Multiple New Agreements for Access to ActivMAb Antigen Virus TechnologyFebruary 21, 2024 | finanznachrichten.deVaccinex Enters Antibody Discovery Agreements Incorporating ActivMAb Drug Discovery PlatformFebruary 21, 2024 | markets.businessinsider.comVaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyFebruary 21, 2024 | finance.yahoo.comVaccinex Announces Multiple New Agreements for Access to ActivMAb® Antigen Virus TechnologyFebruary 21, 2024 | globenewswire.comTrading was temporarily halted for "VCNX" at 07:02 PM with a stated reason of "News pending."February 19, 2024 | marketbeat.comVaccinex Announces 1-For-14 Reverse Stock SplitFebruary 15, 2024 | markets.businessinsider.comWhy Vaccinex (VCNX) Stock Is Trading LowerFebruary 15, 2024 | msn.comVaccinex, Inc. Announces Reverse Stock SplitFebruary 15, 2024 | globenewswire.comSteven Cohen's Point72 Asset Management Acquires New Stake in Vaccinex IncFebruary 12, 2024 | finance.yahoo.comVaccinex Inc Secures $3.7M in Private Placement DealFebruary 8, 2024 | msn.comWhy Vaccinex (VCNX) Stock Is Popping OffFebruary 7, 2024 | msn.comVaccinex Announces Pricing of $3.7 Million PIPE FinancingFebruary 7, 2024 | markets.businessinsider.comNasdaq Grants Vaccinex Extension Until March 4, 2024 to Regain Compliance with Listing RuleDecember 4, 2023 | finance.yahoo.comVaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNovember 13, 2023 | finance.yahoo.comVaccinex Reports Clinical Benefit in Interim Analyses from two Phase 2 Studies of Pepinemab Combination Treatment at Society for Immunotherapy of Cancer’s Annual MeetingOctober 31, 2023 | finance.yahoo.com Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address VCNX Media Mentions By Week VCNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VCNX News Sentiment▼0.000.63▲Average Medical News Sentiment VCNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VCNX Articles This Week▼01▲VCNX Articles Average Week Get Vaccinex News Delivered to You Automatically Sign up to receive the latest news and ratings for VCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BCLI News Today AYTU News Today PHXM News Today APLM News Today HOTH News Today TSBX News Today ENSC News Today CLRB News Today BCDA News Today JAGX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VCNX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts